These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28238947)
81. A unique multifunctional transporter translocates estradiol-17beta -glucuronide in rat liver microsomal vesicles. Battaglia E; Gollan J J Biol Chem; 2001 Jun; 276(26):23492-8. PubMed ID: 11313362 [TBL] [Abstract][Full Text] [Related]
82. Predicting Drug-Induced Liver Injury with Bayesian Machine Learning. Williams DP; Lazic SE; Foster AJ; Semenova E; Morgan P Chem Res Toxicol; 2020 Jan; 33(1):239-248. PubMed ID: 31535850 [TBL] [Abstract][Full Text] [Related]
83. Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors. Zhou WN; Zhang YM; Qiao X; Pan J; Yin LF; Zhu L; Zhao JN; Lu S; Lu T; Chen YD; Liu HC Curr Comput Aided Drug Des; 2019; 15(3):193-205. PubMed ID: 30411690 [TBL] [Abstract][Full Text] [Related]
84. Predicting drug-induced liver injury in human with Naïve Bayes classifier approach. Zhang H; Ding L; Zou Y; Hu SQ; Huang HG; Kong WB; Zhang J J Comput Aided Mol Des; 2016 Oct; 30(10):889-898. PubMed ID: 27640149 [TBL] [Abstract][Full Text] [Related]
85. Mrp3 Transports Clopidogrel Acyl Glucuronide from the Hepatocytes into Blood. Ji JZ; Tai T; Huang BB; Gu TT; Mi QY; Xie HG Drug Metab Dispos; 2018 Feb; 46(2):151-154. PubMed ID: 29196299 [TBL] [Abstract][Full Text] [Related]
86. Prediction model of human ABCC2/MRP2 efflux pump inhibitors: a QSAR study. Le MT; Phan TV; Tran-Nguyen VK; Tran TD; Thai KM Mol Divers; 2021 May; 25(2):741-751. PubMed ID: 32048150 [TBL] [Abstract][Full Text] [Related]
87. Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1. Kamo S; Nakanishi T; Aotani R; Nakamura Y; Gose T; Tamai I J Pharm Sci; 2017 Sep; 106(9):2483-2490. PubMed ID: 28479361 [TBL] [Abstract][Full Text] [Related]
88. Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches. Zhao Y; Zhang Z; Kong X; Wang K; Wang Y; Jia J; Li H; Tian S Chem Biol Drug Des; 2024 Aug; 104(2):e14607. PubMed ID: 39179521 [TBL] [Abstract][Full Text] [Related]
89. Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3/Abcc3) facilitates intestinal absorption of folates in mouse. Kitamura Y; Kusuhara H; Sugiyama Y Pharm Res; 2010 Apr; 27(4):665-72. PubMed ID: 20148291 [TBL] [Abstract][Full Text] [Related]
90. Tissue distribution and induction of human multidrug resistant protein 3. Scheffer GL; Kool M; de Haas M; de Vree JM; Pijnenborg AC; Bosman DK; Elferink RP; van der Valk P; Borst P; Scheper RJ Lab Invest; 2002 Feb; 82(2):193-201. PubMed ID: 11850532 [TBL] [Abstract][Full Text] [Related]
91. Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters-An in Silico Modeling Approach. Kotsampasakou E; Ecker GF J Chem Inf Model; 2017 Mar; 57(3):608-615. PubMed ID: 28166633 [TBL] [Abstract][Full Text] [Related]
92. Multidrug resistance-associated protein 3 (Mrp3/Abcc3/Moat-D) is expressed in the SAE Squalus acanthias shark embryo-derived cell line. Kobayashi H; Parton A; Czechanski A; Durkin C; Kong CC; Barnes D Zebrafish; 2007; 4(4):261-75. PubMed ID: 18284333 [TBL] [Abstract][Full Text] [Related]
93. A structure-activity relationship study of ABCC2 inhibitors. Wissel G; Deng F; Kudryavtsev P; Ghemtio L; Wipf P; Xhaard H; Kidron H Eur J Pharm Sci; 2017 May; 103():60-69. PubMed ID: 28185990 [TBL] [Abstract][Full Text] [Related]
94. In silico prediction of multiple-category classification model for cytochrome P450 inhibitors and non-inhibitors using machine-learning method. Lee JH; Basith S; Cui M; Kim B; Choi S SAR QSAR Environ Res; 2017 Oct; 28(10):863-874. PubMed ID: 29183231 [TBL] [Abstract][Full Text] [Related]
96. Early Drug-Induced Liver Injury Risk Screening: "Free," as Good as It Gets. Martin MT; Koza-Taylor P; Di L; Watt ED; Keefer C; Smaltz D; Cook J; Jackson JP Toxicol Sci; 2022 Jul; 188(2):208-218. PubMed ID: 35639956 [TBL] [Abstract][Full Text] [Related]
97. Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs. Zhang H; Zhang HR; Hu ML; Qi HZ J Pharmacol Toxicol Methods; 2022; 116():107185. PubMed ID: 35623583 [TBL] [Abstract][Full Text] [Related]
98. Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data. Ye L; Ngan DK; Xu T; Liu Z; Zhao J; Sakamuru S; Zhang L; Zhao T; Xia M; Simeonov A; Huang R Toxicol Appl Pharmacol; 2022 Nov; 454():116250. PubMed ID: 36150479 [TBL] [Abstract][Full Text] [Related]
99. Predicting Drug-Induced Liver Injury Using Ensemble Learning Methods and Molecular Fingerprints. Ai H; Chen W; Zhang L; Huang L; Yin Z; Hu H; Zhao Q; Zhao J; Liu H Toxicol Sci; 2018 Sep; 165(1):100-107. PubMed ID: 29788510 [TBL] [Abstract][Full Text] [Related]